Atrovent UDV TM
Listen to the Pronunciation:
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: ipratropium
Brand name
(ARTG)
: ATROVENT UNIT DOSE VIALS ipratropium bromide 250 micrograms/1 mL (as monohydrate) conventional inhalation ampouleConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Moderate asthmatic attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery, use during assisted ventilation with a respirator. Administration of Atrovent via a nebuliser is intended for those patients who cannot use a metered dose aerosol.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Inhalation, conventional
- Inhalation
- Clear colourless or almost colourless liquid free from suspended particles
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Light
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 10 x 1mL pack
- 30 x 1mL pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ipratropium
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems